LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.39 | 770.25 | 2373 | 2244 | 1.0573 | 1.0735 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.62 | 770.25 | 2930 | 2514 | 1.1651 | 1.1872 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.62 | 770.25 | 2646 | 2514 | 1.0521 | 1.0604 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.84 | 770.25 | 3254 | 2833 | 1.1483 | 1.1527 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.84 | 770.25 | 2988 | 2833 | 1.0544 | 1.0572 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 30.06 | 770.25 | 3607 | 3106 | 1.1613 | 1.1543 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 30.06 | 770.25 | 3282 | 3106 | 1.0566 | 1.0555 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 32.28 | 770.25 | 3910 | 3392 | 1.1524 | 1.1371 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 32.28 | 770.25 | 3570 | 3392 | 1.0522 | 1.0481 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 34.50 | 770.25 | 4234 | 3712 | 1.1406 | 1.1194 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 34.50 | 770.25 | 3927 | 3712 | 1.0579 | 1.0503 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.73 | 770.25 | 4690 | 4086 | 1.1478 | 1.1179 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.73 | 770.25 | 4280 | 4086 | 1.0474 | 1.0389 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.95 | 770.25 | 5169 | 4543 | 1.1376 | 1.1033 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.95 | 770.25 | 4751 | 4543 | 1.0456 | 1.0351 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.17 | 770.25 | 5659 | 5010 | 1.1294 | 1.0921 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.17 | 770.25 | 5245 | 5010 | 1.0468 | 1.0341 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.39 | 770.25 | 6060 | 5404 | 1.1213 | 1.0832 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.39 | 770.25 | 5671 | 5404 | 1.0493 | 1.0346 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.61 | 770.25 | 6502 | 5813 | 1.1185 | 1.0783 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.61 | 770.25 | 6086 | 5813 | 1.0470 | 1.0317 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.83 | 770.25 | 7073 | 6223 | 1.1365 | 1.0867 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.83 | 770.25 | 6549 | 6223 | 1.0523 | 1.0341 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 50.05 | 770.25 | 7518 | 6629 | 1.1340 | 1.0827 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 50.05 | 770.25 | 6969 | 6629 | 1.0512 | 1.0324 | MN20160304_L02 | N15 |